Literature DB >> 698212

The synergism of cardiotoxin and phospholipase A2 in hemolysis.

A I Louw, L Visser.   

Abstract

The synergistic effect of exogenous cobra phospholipase A2 on the hemolysis brate of guinea pig erythrocytes by highly purified snake venom cardiotoxins was investigated. In the presence of phospholipase A2 the reaction was not only faster and had a lower activation energy but followed a sigmoidal instead of a linear time course. Similar results were obtained using porcine pancreatic phospholipase A2. Significantly, addition of even a trace of cobra phospholipase A2 (approx. 0.1%, w/w) was sufficient to bring about the full synergistic effect, emphasizing the stringent purity requirements for any meaningful investigation of cardiotoxin's own action. The possibility that the action of cardiotoxin on its own may involve the stimulation of an endogenous phospholipase is discussed in the light of the results obtained with exogenous cobra enzyme.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 698212     DOI: 10.1016/0005-2736(78)90227-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Model of interaction between a cardiotoxin and dimyristoylphosphatidic acid bilayers determined by solid-state 31P NMR spectroscopy.

Authors:  F Picard; M Pézolet; P E Bougis; M Auger
Journal:  Biophys J       Date:  1996-04       Impact factor: 4.033

2.  Cellular responses to Pyrularia thionin are mediated by Ca2+ influx and phospholipase A2 activation and are inhibited by thionin tyrosine iodination.

Authors:  J Evans; Y D Wang; K P Shaw; L P Vernon
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

3.  VRCTC-310--a novel compound of purified animal toxins separates antitumor efficacy from neurotoxicity.

Authors:  R A Newman; J C Vidal; L J Viskatis; J Johnson; M A Etcheverry
Journal:  Invest New Drugs       Date:  1993 May-Aug       Impact factor: 3.850

4.  Anticoagulant Activity of Naja nigricollis Venom Is Mediated by Phospholipase A2 Toxins and Inhibited by Varespladib.

Authors:  Taline D Kazandjian; Arif Arrahman; Kristina B M Still; Govert W Somsen; Freek J Vonk; Nicholas R Casewell; Mark C Wilkinson; Jeroen Kool
Journal:  Toxins (Basel)       Date:  2021-04-23       Impact factor: 4.546

5.  Unity Makes Strength: Exploring Intraspecies and Interspecies Toxin Synergism between Phospholipases A2 and Cytotoxins.

Authors:  Manuela B Pucca; Shirin Ahmadi; Felipe A Cerni; Line Ledsgaard; Christoffer V Sørensen; Farrell T S McGeoghan; Trenton Stewart; Erwin Schoof; Bruno Lomonte; Ulrich Auf dem Keller; Eliane C Arantes; Figen Çalışkan; Andreas H Laustsen
Journal:  Front Pharmacol       Date:  2020-05-07       Impact factor: 5.810

6.  Biogeographical venom variation in the Indian spectacled cobra (Naja naja) underscores the pressing need for pan-India efficacious snakebite therapy.

Authors:  R R Senji Laxme; Saurabh Attarde; Suyog Khochare; Vivek Suranse; Gerard Martin; Nicholas R Casewell; Romulus Whitaker; Kartik Sunagar
Journal:  PLoS Negl Trop Dis       Date:  2021-02-18

7.  The myth of cobra venom cytotoxin: More than just direct cytolytic actions.

Authors:  Jia Jin Hiu; Michelle Khai Khun Yap
Journal:  Toxicon X       Date:  2022-04-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.